FDA Inspection
CRM Alabama LLCCRM Alabama LLC – FDA Inspection, Jun 4, 2018
Record Details
This FDA Inspection record concerns CRM Alabama LLC, with an inspection on June 4, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · c5a9dcb7-0d28-48ae-82e5-b8e3bb2e476d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1054221
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 1271.47(a)Testing, screening, donor eligibility procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CRM Alabama LLC
6| Date | Classification | Office | Project area |
|---|---|---|---|
| July 25, 2024 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 19, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 10, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 23, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 22, 2012 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for CRM Alabama LLC
- FDA Inspection 1245882 - 2024-07-25
- FDA Inspection 1168733 - 2022-04-19
- FDA Inspection 951056 - 2015-12-10
- FDA Inspection 859992 - 2013-12-23
- FDA Inspection 788044 - 2012-06-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.